TrialThe New England journal of medicine2018

VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.

Dominic Keating et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.